東華大學圖書館 |

Improvements in Pulmonary Tissue Engineering: Toward Functional Tracheal and Lung Replacements.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Improvements in Pulmonary Tissue Engineering: Toward Functional Tracheal and Lung Replacements./
作者:	Greaney, Allison M.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	327 p.
附註:	Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
Contained By:	Dissertations Abstracts International83-02B.
標題:	Bioengineering. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28322188
ISBN:	9798534651782

Improvements in Pulmonary Tissue Engineering: Toward Functional Tracheal and Lung Replacements.
Greaney, Allison M.

Improvements in Pulmonary Tissue Engineering: Toward Functional Tracheal and Lung Replacements. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 327 p.

Source: Dissertations Abstracts International, Volume: 83-02, Section: B.

Thesis (Ph.D.)--Yale University, 2021.

This item is not available from ProQuest Dissertations & Theses.

Tissue engineering offers a uniquely powerful solution for the regeneration of damaged or diseased tissues, in the form of personalized living replacements. Building such replacements, however, requires a deep appreciation for the biological, chemical, and engineering aspects that govern their function. Currently, the generation of biomimetic trachea and lung replacements is hampered by incomplete recapitulation of certain of these critical aspects, which have been addressed through the work in this thesis.In Chapter 2, I reviewed all reported clinical applications of engineered tracheal grafts to replace long-segment, circumferential damage from 1898 to 2018. From these reports, I identified the current gold-standard in clinical tracheal replacement to be the Leuven protocol, based on patient survival and follow-up time. By collating graft-related causes of mortality, I generated a list of clinical care priorities and critical design criteria that will inform future efforts to generate engineered tracheal replacement grafts.In Chapter 3, I addressed the biomechanics of engineered tracheal grafts, which is a leading cause of tracheal graft failure. I evaluated 3D bulk mechanical properties of native and decellularized tracheas, isolating behaviors of each structural component of the trachea (cartilage, smooth muscle, and connective tissue). I then correlated mechanical deviations from native trachea, to structural changes to the extracellular matrix with decellularization treatment. Taken together, decellularized tracheal grafts possessed significantly impaired mechanical properties and protein structures compared to native, which should discourage their application clinically.In Chapter 4, I evaluated platform-specific effects on the differentiation of a novel population of pharmacologically expanded, primary basal cells (peBC). This work determined that artificial culture platforms, including air-liquid interface (ALI) and organoid cultures, impart non-physiologic artifacts on cellular response in these systems. Conversely, decellularized trachea and lung scaffolds impart region-specific differentiation cues on cultured peBC, which generate more physiologic cellular outcomes. This work represents the first published evaluation of engineered tissues by single-cell RNA sequencing (scRNAseq).In Chapter 5, I leveraged scRNAseq methodologies from Chapter 4 to evaluate SARS-CoV-2 viral infection dynamics in an ALI model of human proximal epithelium. This work identified a novel mechanism of viral entry via ciliated cells, which further elucidated a mechanism of enhanced system vulnerability on infection.In Chapter 6, I characterized the immune landscape of the postnatal developing rat lung by scRNAseq. I identified 26 distinct cell types and elucidated patterns of immune cell colonization, differentiation, and maturation. I also identified putative roles for certain immune cell types in regulating and contributing to the developing lung matrix morphology.In Chapter 7, I leveraged peBC in whole-lung engineered cultures to enhance epithelial barrier function, in co-culture with endothelium, fibroblasts, and/or pulmonary macrophages. I also further improved engineered lung culture paradigms to enhance tissue homogeneity and maturation. By scRNAseq evaluation of engineered lung epithelium, I found that peBC differentiate away from a proximal epithelial phenotype, and rather than gaining canonical distal epithelial character, gains a novel phenotype of regenerative, barrier-forming epithelium that resembles that observed in various disease states.Taken together, the work in this thesis represents significant strides toward generating functional engineered tracheal and lung replacements.

ISBN: 9798534651782Subjects--Topical Terms:

657580
Bioengineering.
Subjects--Index Terms:

Biomechanics

Improvements in Pulmonary Tissue Engineering: Toward Functional Tracheal and Lung Replacements.
LDR:05102nmm a2200433 4500 001 2352001
005 20221111120950.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798534651782
035 $a (MiAaPQ)AAI28322188
035 $a AAI28322188
040 $a MiAaPQ $c MiAaPQ
100 1 $a Greaney, Allison M. $3 3691611
245 1 0 $a Improvements in Pulmonary Tissue Engineering: Toward Functional Tracheal and Lung Replacements.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 327 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
500 $a Advisor: Niklason, Laura.
502 $a Thesis (Ph.D.)--Yale University, 2021.
506 $a This item is not available from ProQuest Dissertations & Theses.
506 $a This item must not be sold to any third party vendors.
520 $a Tissue engineering offers a uniquely powerful solution for the regeneration of damaged or diseased tissues, in the form of personalized living replacements. Building such replacements, however, requires a deep appreciation for the biological, chemical, and engineering aspects that govern their function. Currently, the generation of biomimetic trachea and lung replacements is hampered by incomplete recapitulation of certain of these critical aspects, which have been addressed through the work in this thesis.In Chapter 2, I reviewed all reported clinical applications of engineered tracheal grafts to replace long-segment, circumferential damage from 1898 to 2018. From these reports, I identified the current gold-standard in clinical tracheal replacement to be the Leuven protocol, based on patient survival and follow-up time. By collating graft-related causes of mortality, I generated a list of clinical care priorities and critical design criteria that will inform future efforts to generate engineered tracheal replacement grafts.In Chapter 3, I addressed the biomechanics of engineered tracheal grafts, which is a leading cause of tracheal graft failure. I evaluated 3D bulk mechanical properties of native and decellularized tracheas, isolating behaviors of each structural component of the trachea (cartilage, smooth muscle, and connective tissue). I then correlated mechanical deviations from native trachea, to structural changes to the extracellular matrix with decellularization treatment. Taken together, decellularized tracheal grafts possessed significantly impaired mechanical properties and protein structures compared to native, which should discourage their application clinically.In Chapter 4, I evaluated platform-specific effects on the differentiation of a novel population of pharmacologically expanded, primary basal cells (peBC). This work determined that artificial culture platforms, including air-liquid interface (ALI) and organoid cultures, impart non-physiologic artifacts on cellular response in these systems. Conversely, decellularized trachea and lung scaffolds impart region-specific differentiation cues on cultured peBC, which generate more physiologic cellular outcomes. This work represents the first published evaluation of engineered tissues by single-cell RNA sequencing (scRNAseq).In Chapter 5, I leveraged scRNAseq methodologies from Chapter 4 to evaluate SARS-CoV-2 viral infection dynamics in an ALI model of human proximal epithelium. This work identified a novel mechanism of viral entry via ciliated cells, which further elucidated a mechanism of enhanced system vulnerability on infection.In Chapter 6, I characterized the immune landscape of the postnatal developing rat lung by scRNAseq. I identified 26 distinct cell types and elucidated patterns of immune cell colonization, differentiation, and maturation. I also identified putative roles for certain immune cell types in regulating and contributing to the developing lung matrix morphology.In Chapter 7, I leveraged peBC in whole-lung engineered cultures to enhance epithelial barrier function, in co-culture with endothelium, fibroblasts, and/or pulmonary macrophages. I also further improved engineered lung culture paradigms to enhance tissue homogeneity and maturation. By scRNAseq evaluation of engineered lung epithelium, I found that peBC differentiate away from a proximal epithelial phenotype, and rather than gaining canonical distal epithelial character, gains a novel phenotype of regenerative, barrier-forming epithelium that resembles that observed in various disease states.Taken together, the work in this thesis represents significant strides toward generating functional engineered tracheal and lung replacements.
590 $a School code: 0265.
650 4 $a Bioengineering. $3 657580
650 4 $a Biomedical engineering. $3 535387
650 4 $a Cellular biology. $3 3172791
650 4 $a Medicine. $3 641104
650 4 $a Genetics. $3 530508
650 4 $a Teaching. $3 517098
650 4 $a Kinases. $3 3558077
650 4 $a Coronaviruses. $3 894828
650 4 $a COVID-19. $3 3554449
653 $a Biomechanics
653 $a Lung replacement
653 $a Regenerative medicine
653 $a RNA sequencing
653 $a Tissue engineering
653 $a Trachea
653 $a Pulmonary tissue
690 $a 0202
690 $a 0541
690 $a 0379
690 $a 0564
690 $a 0369
710 2 $a Yale University. $b Biomedical Engineering. $3 3691612
773 0 $t Dissertations Abstracts International $g 83-02B.
790 $a 0265
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28322188